Resectable Non-Small-Cell Lung Cancer trials recruiting in New York

Fewer than 3 recruiting trials found.

All Resectable Non-Small-Cell Lung Cancer trials nationally

1

Recruiting in New York

1

Cities with sites

Cities in New York

The Bronx 1

Recruiting trials in New York

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
NCT04198766 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: The Bronx

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.